Catalyst Wire Dossier Catalyst Wire Dossier

Partially HLA-matched Third Party Antigen Specific T-cells

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Partially HLA-matched Third Party Antigen Specific T-cells, covering 2016-07-21 to 2016-07-21. Get the full timeline:

Most recent: Clinical Trial Update: Partially HLA-matched Third Party Antigen Specific T-cells for Infection Post-stem Cell or Solid Organ Transplantation [Phase 1]

See pricing